D.E. Shaw & Co
HGEN

D.E. Shaw & Co’s HUMANIGEN, INC. HGEN Stock Holding History

D.E. Shaw & Co’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-352,853
Closed -$624K – 5682
2022
Q2 		$624K Sell
352,853
-294,438
-45% -$661K ﹤0.01% 3968
2022
Q1 		$1.95M Buy
647,291
+194,208
+43% +$520K ﹤0.01% 3327
2021
Q4 		$1.69M Sell
453,083
-16,471
-4% -$96.4K ﹤0.01% 3510
2021
Q3 		$2.78M Buy
469,554
+171,856
+58% +$2.41M ﹤0.01% 2702
2021
Q2 		$5.17M Buy
+297,698
New +$5.43M ﹤0.01% 2007

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co's HGEN Position: Q3 2022 in Review

D.E. Shaw & Co sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 352,853 shares — an estimated $624K sold.

D.E. Shaw & Co first reported a position in HGEN in Q2 2021 and held it in 5 quarters. The position peaked at $5.17M in Q2 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • D.E. Shaw & Co reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 352,853 HUMANIGEN, INC. shares in Q3 2022, an estimated $624K.
  • D.E. Shaw & Co first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's HUMANIGEN, INC. position peaked at $5.17M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.